New Daily HIV Pill Moves Closer to Approval
A Phase 3 clinical study from Merck will look at the use of islatravir for treatment after it was studied for preventative use.
September 28 2022 9:36 AM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A Phase 3 clinical study from Merck will look at the use of islatravir for treatment after it was studied for preventative use.
Martin Shkreli, the bully who hiked up the price of an HIV drug nearly 5,000 percent overnight, now faces up to 20 years in prison.
A trial drug study will be conducted on Multikine, which has the potential to work with the immune system against tumors and warts created by HPV and HPV/HIV co-infection.